Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001066600 | SCV001231615 | pathogenic | Zellweger spectrum disorders | 2023-09-03 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 591770). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with PEX1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser241Glnfs*2) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 21031596, 26387595, 31831025). |
Baylor Genetics | RCV003472259 | SCV004203270 | likely pathogenic | Heimler syndrome 1 | 2023-10-16 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005036036 | SCV005669736 | likely pathogenic | Peroxisome biogenesis disorder 1A (Zellweger); Heimler syndrome 1; Peroxisome biogenesis disorder 1B | 2024-04-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000722952 | SCV005874938 | likely pathogenic | not provided | 2024-08-28 | criteria provided, single submitter | clinical testing | Reported in a patient with retinitis pigmentosa who also harbored an apparently homozygous variant in the CERKL gene that may have been responsible for the phenotype (PMID: 35318874); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 35318874) |
Gharavi Laboratory, |
RCV000722952 | SCV000854083 | uncertain significance | not provided | 2018-09-16 | no assertion criteria provided | research |